| abstract |
The present disclosure provides oral dosage forms comprising a cephalotaxine and a pharmaceutically acceptable carrier selected from protein, carbohydrate and lipid, an oral dosage form comprising cephalotaxine and a second active agent, as well as methods of treating subjects with such oral formulations. R, < NN HO -- C -0z-C0- H/ H H-C -C 2 -CH 2 H2 f I H3i COO-CH |